Molecular Dynamics Simulations of the Ligand-Induced Chemical Information Transfer in the 5-HT1A Receptor

Journal of Chemical Information and Computer Sciences

Volumn 43, Issue 5, 2003, Pages 1520-1531

  Seeber, Michele ^a   De Benedetti, Pier G ^a   Fanelli, Francesca ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; COMPUTER SIMULATION; MOLECULAR DYNAMICS; MOLECULAR STRUCTURE; PROTEINS;

BIORECEPTORS;

BIOCHEMISTRY;

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; LIGAND; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN; SEROTONIN 1A RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG POTENTIATION; KINETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE; THERMODYNAMICS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMINO ACID SEQUENCE; COMPUTER SIMULATION; KINETICS; LIGANDS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PIPERAZINES; PROTEIN STRUCTURE, SECONDARY; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; THERMODYNAMICS;

EID: 0141890725     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci034069c     Document Type: Article

References (48)

1. Gether, U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 2000, 21, 90-113, and references therein.
2. Arvanitakis, L.; Geras-Raaka, E.; Gershengorn, M. C. Constitutively Signaling G-protein coupled receptor and human disease. Trends Endocrinol Metab. 1998, 9, 27-31, and references therein.
3. Coleman, D. E.; Sprang, S. How G proteins work: a continuing story. TIBS 1996, 21, 41-44, and references therein.
4. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
5. 3-muscarinic receptors. Prot. Eng. 1995, 8, 557-564.
6. 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. Embo J. 1996, 15, 3566-3578.
7. Scheer, A.; Fanelli, F.; Costa, T.; De Benedetti, P. G.; Cotecchia, S. The activation process of the ctis-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 808-813.
8. Fanelli, P.; Menziani, M. C.; Scheer, A.; Cotecchia, S.; De Benedetti, P. G. Ab initia modeling and molecular dynamics simulation of the α1b-adrenergic receptor activation. Methods Companion Methods Emymol. 1998 14, 302-317, and references therein.
9. Fanelli, F.; Menziani, M. C.; Scheer, A.; Cotecchia, S.; De Benedetti, P. G. Theoretical study of the electrostatically driven step of receptor-G protein recognition. PROTEINS: Struct. Fund. Genetics 1999, 37, 145-156.
10. Fanelli, F.; Menziani, M. C.; Scheer, A.; Cotecchia, S.; De Benedetti, P. G. Theoretical study on receptor/G protein recognition: new insights into the mechanism of the au,-adrenergic receptor activation. Int. J. Quantum Chem. 1999, 73, 71-83.
11. Fanelli, F.; Barbier, P.; Zanchetta, D.; De Benedetti, P. G.; Chini, B. Activation Mechanism of Human Oxytocin Receptor: A Combined Study of Experimental and Computer-Simulated Mutagenesis. Mol. Pharmacol. 1999, 50, 214-225.
12. Fanelli, F. Theoretical study on mutation-induced activation of the luteinizing hormone receptor. J. Mol. Biol. 2000, 296, 1333-1351.
13. Greasley, P. J.; Fanelli, F.; Scheer, A.; Abuin, L.; Nenniger-Tosato, M. ; De Benedetti, P. G.; Cotecchia. S. Mutational and computational analysis of the α1b-adrenergic receptor: involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J. Biol Chem. 2001, 276, 46485-46494.
14. 1b-adrenergic receptor highlight the role of helix3/helix 6 interface in receptor activation. Mol. Pharmacol. 2002, 61, 1-8.
15. Angelova, K.; Fanelli, F.; Puett, D. Engineered and Simulated Mutations in Transmembrane Helices 6 and 7 of the Lutropin Receptor: A Model for Constitutive and Ligand-mediated Receptor Activation. J. Biol. Chem, 2002, 277, 32202-32213.
16. 1A receptor and ligands. Prot. Eng. 1993, 6, 691-700.
17. 1A receptor interactions. Prot. Eng. 1996, 9, 149-160.
18. 1A receptor interactions. J. Med. Chem. 1996, 39, 3491-3502.
19. 1A receptor. J. Pharm. Pharmacol. 1997, 49, 698-705.
20. 1Adrenergic receptor affinity by classical Hansch analysis, artificial neural networks, and computational simulation of ligand recognition. J. Med. Chem. 2001, 44, 198-207.
21. LòpezRodrìguez, M. L.; Vicente, B.; Deupi, X.; Barrondo, S.; Olivella, M.; Morcillo, M. J.; Behamù, B.; Ballesteros, J.; Sallès, J.; Pardo, L. Design, synthesis and pharmacological evaluation of 5-hydroxytryptamine 1a receptor ligands to explore the three-dimensional structure of the receptor. Mol. Pharmacol. 2002, 62, 15-21.
22. 1A receptor. Eur. J. Pharmacol. 2001, 416, 33-41.
23. 1 receptor ligands: update 1997. Current Drugs 1997, 2, 351-372, and references therein.
24. Sali, A.; Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234, 779-815.
25. Ballesteros, J. A.; Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 1995, 25, 366-428.
26. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. Charmm: a program for macromolecular energy, minimization and dynamics calculations. J. Comput. Chem. 1983, 4, 187-217.
27. Farrens, D. L.; Altenbach, C.; Yang, K.; Hubbell, W. L.; Khorana, H. G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 1996, 274, 768-770.
28. Chothia, C.; Lesk, A. M. The relation between the divergence of sequence and structure in proteins. Embo J. 1986, 5, 823-826.
29. 1A receptor: a site-directed mutation study. FEBS 1992, 312, 259-262.
30. Peroutka, S. J. Molecular Biology of serotonin (5-HT) receptors. Synapse 1994, 18, 241-260, and references therein.
31. Dewar, M. J. S.; Zoebisch, E. G.; Healey E. F.; Stewart, J. J. P. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
32. 1A serotoninergic ligands. J. Mol. Struct. (THEOCHEM) 1997, 397, 129-145.
33. 1A receptor. Mol. Pharmacol. 1997, 51, 889-896.
34. 1b-adrenergic receptor is a key switch residue involved in activation and catecholmine ring aromatic bonding. J. Biol. Chem. 1999, 274, 16320-16330.
35. 1B-adrenergic receptor involved in agonist binding: further differences in docking catecholamines to receptor subtypes. FEBS Lett. 1996, 399, 9-13.
36. Okada, T.; Fujiyoshi, Y.; Silow, M.; Navarro, J.; Landau, E. M.; Shichida, Y. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. PNAS 2002, 99, 5982-5987.
37. 1A receptor agonists in reeombinant cell lines. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 356, 551-561.
38. Amis, S.; Fahmy, K.; Hofmann, K. P.; Sakmar, T. P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 1994, 269, 23879-23881.
39. Kim, J. M.; Altenbach, C.; Thurmond, R. L.; Khorana, H. G.; Hubbell, W. L. Structure and function in rhodopsin: rhodopsin mutants with a neutral amino acid at E134 have a partially activated conformation in the dark state. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 14273-14278.
40. Cotecchia, S.; Fanelli, F.; Scheer, A.; De Benedetti, P. G. In Receptor Biochemistry and Methodology; Strader, C., Sibley, D., Eds.; Wiley-Liss Pub.: New York, 1999; Vol. III (Structure/function analysis of GPCRs; Wess, J., Ed.), pp 167-183, and references therein.
41. Ballesteros, J. A.; Jensen, A. D.; Liapakis, G.; Rasmussen, S. G.; Shi, L.; Gether, U.; Javitch. J. A. Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 2001, 276, 29171-29177.
42. Shapiro, D. A.; Kristiansen, K.; Weiner, D. M.; Kroeze, W. K.; Roth, B. L. J. Evidence for a model of agonist induced activation of 5Hydroxytryptamine2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem. 2002, 277, 11441-11449.
43. 2A receptor by disruption of the ionic lock of the arginine cage. Int. J. Quantum Chem. 2002, 88, 65-75.
44. Huang, P.; Li, J.; Chen, C.; Visiers, I.; Weinstein, H.; LiuChen, L.-J. Functional Role of a Conserved Motif in TM6 of the Rat μ Opioid Receptor: Constitutively Active and Inactive Receptors Result from Substitutions of Thr6.34(279) with Lys and Asp. Biochemistry 2001, 40, 13501-13509.
45. Sansom, M. S. P.; Weinstein, H. Hinges, swilves and switches: the role of prolines in signaling via transmembrane α-helices. TiPS 2000, 21, 445-451, and references therein.
46. 2 receptor is accessible in the binding-site crevice. Biochemistry 1998, 37, 998-1006.
47. 1A receptors. Ear. J. Pharmacol. 1996, 307, 107-111.
48. Meng, E. C.; Bourne, H. Receptor activation: what does rhodopsin structure tell us? Trends Pharmacol. Sci. 2001, 22, 587-593, and references therein.